Replies to post #796696 on NorthWest Biotherapeutics Inc (NWBO)

[eagle8]

JFR161162,
You wrote : " $3B-$5B valuations make way more sens for an approved cell therapies".

I'd say start by adding a zero after both numbers.
Just think of the acquisitions of companies we've seen here (without Ph3 results, let alone approvals) for amounts of $21B and higher, which, in terms of product, don't even come close to what's already known about NWBO with DCvax, Advent, Roswell, and others.
If you factor that in and then look at the POTENTIAL of the new PLATFORM and CAN give it a realistic value, I think our short friends here will be terrified.
But I think they already know this.
Hence the fear.

GLTU